Presentation TCT 2013 ReZolve Sirolimus-eluting BRS Based on an Iodinated Tyrosine Derivative: Device Iteration and Extended Imaging and Clinical Results Presenter: Ricardo Costa October 27, 2013
Presentation TCT 2013 Chemical Ablation for Renal Denervation (Northwind Technologies) Presenter: Mark Wholey October 27, 2013
Presentation TCT 2013 No: In Fact, the Lack of Control Will Lead to Unpredictable Safety and Efficacy Outcomes! Presenter: Jochen W?hrle October 27, 2013
Presentation TCT 2013 Device and Clinical Trial Update: EnligHTN (St. Jude) Presenter: Stephen Worthley October 27, 2013
Presentation TCT 2013 Direct Aortic Access is the Preferred (Non-transfemoral) Alternative Presenter: Michael Reardon October 27, 2013
Presentation TCT 2013 Cost-Effectiveness Considerations for Mild and Moderate Hypertension Presenter: Mark Hlatky October 27, 2013
Presentation TCT 2013 Based on the Current Data, Durable Polymer DES Offer Early and Late Clinical Advantages! Presenter: Sripal Bangalore October 27, 2013